Global Spot Monitor Market - 2024-2031

Overview

The global spot monitor market reached US$ 7.41 billion in 2023 and is expected to reach US$ 12.41 billion by 2031, growing at a CAGR of 6.7% during the forecast period 2024-2031.

A spot monitor is a medical device that captures a single vital signs measurement, providing a quick "snapshot" of a patient's condition at a specific moment. This capability is essential for healthcare professionals to assess and monitor patient health efficiently.

The rising incidence of chronic diseases such as cardiovascular diseases (CVDs), including heart failure, arrhythmias, coronary artery disease, respiratory diseases, diabetes, and neurology diseases are the significant driver for the spot monitors market. For instance, according to CDC data in October 2024, heart disease is indeed the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 33 seconds from cardiovascular disease. In 2022, 702,880 people died from heart disease. All these factors demand the spot monitors market.

Market Dynamics: Drivers & Restraints

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases is significantly driving the growth of the spot monitor market and is expected to drive throughout the market forecast period.

The rise in lifestyle-related chronic conditions such as cardiovascular diseases, diabetes, and respiratory illnesses necessitates continuous and accurate monitoring of vital signs. This trend drives the demand for effective spot-monitoring solutions that provide timely data for better disease management.

According to WHO data in September 2023, NCDs are responsible for 41 million deaths annually, making them the leading cause of mortality globally. Each year, about 17 million people die from NCDs before reaching the age of 70. A staggering 86% of premature NCD deaths occur in low- and middle-income countries. 77% of all NCD deaths happen in these regions. All these factors demand the spot monitors market.

Furthermore, key players' strategies such as partnerships and collaborations would drive the cardiac rhythm management devices market growth. For instance, in June 2023, Royal Philips announced a partnership with BIOTRONIK, a prominent medical device company specializing in cardiovascular and endovascular diseases. This collaboration aims to expand the range of cardiovascular devices available for Philips' SymphonySuite customers, enhancing the offerings for outpatient care settings such as office-based labs (OBLs) and ambulatory surgery centers (ASCs).

Moreover, the growing aging population and technological advancements are the factors expected to drive the spot market over the forecast period.

High cost of devices

The initial investment required for advanced spot monitoring systems can be significant, encompassing not only the cost of the devices themselves but also additional expenses related to training staff and integrating these systems into existing healthcare infrastructures.

Advanced spot monitoring devices can be expensive, often costing thousands of dollars depending on their features and capabilities. For instance, sophisticated models that provide multiple vital sign measurements or integrate with telehealth systems may have higher price points.

For instance, Mindray's ePM 10A Patient Monitor is a vital sign monitoring device designed for healthcare settings. The monitor is listed with a sale price of $4,295.00- $4,695.00. The high cost of devices is expected to hinder spot monitor market growth.

Segment Analysis

The global spot monitor market is segmented based on product type, parameters monitored, application, end-user, distribution channel, and region.

Parameters Monitored :

Vital signs monitoring segment is expected to dominate the spot monitor market share

The vital signs monitoring segment holds a major portion of the spot monitor market share and is expected to continue to hold a significant portion of the spot monitor market share during the forecast period.

Vital signs monitoring are monitoring basic vital signs such as temperature, heart rate, oxygen saturation, and blood pressure. These measures are important for detecting abnormalities in the body. Due to technological advancements, these devices became lightweight, portable, and compact. It is ideal for adults, pediatrics, and even neonates.

Vital signs monitoring plays an important role in detecting diseases. An increase in chronic infections increases the demand and usage. For instance, according to the National Council on Aging, 2023, approximately 95% of adults 60 and older have at least one chronic condition, while more than 80% have two or more. Obesity alone impacts about 42% of adults 60 and older, leading to major conditions like cardiovascular diseases and hypertension, in which Americans hold the highest percentage.

Furthermore, key players in the industry product launches and approvals that would drive this segment growth in the market. For instance, in June 2023, Masimo got 510(K) clearances from the US Food and Drug Administration for its patient-worn, continuous multi-parameter vital signs monitor called Radius VSM. This product enables clinicians to monitor several physiological measurements such as Masimo SET pulse oximetry, temperature, respiration rate, and electrocardiography. These factors have solidified the segment's position in the spot monitor market.

Cardiac monitoring segment is the fastest-growing segment in the spot monitor market share

The cardiac monitoring segment is the fastest-growing segment in the spot monitor market share and is expected to hold the market share over the forecast period.

Cardiac monitoring assists in the continuous examination of a patient's cardiac electrical activity in the form of pressure waveforms. The activity of these devices depends on continuous and intermittent heart activity, usually through electrocardiography. These devices are typically used to diagnose heart aberrations and help in the treatment of serious cardiac disorders such as heart failure, and atrial fibrillation among others.

The rising prevalence of cardiovascular diseases (CVDs) is a significant driving factor for cardiac monitoring devices in the spot monitors market. This increase in cases of CVDs leads to a higher demand for effective monitoring and treatment solutions, directly impacting the growth and expansion of the cardiac monitoring devices market.

According to World Heart Federation data in April 2023, CVDs have been the leading cause of death globally. In 2021, 20.5 million people died from a cardiovascular condition, which accounted for around one-third of all global deaths and was a significant increase from the 12.1 million CVD deaths recorded in 1990. As more individuals are diagnosed with heart-related issues, healthcare providers require effective tools to monitor these patients continuously, leading to an uptick in the adoption of devices like pacemakers, defibrillators, and cardiac resynchronization therapy (CRT) systems.

Geographical Analysis

North America is expected to hold a significant position in the spot monitor market share

North America holds a substantial position in the food as medicine market and is expected to hold most of the market share. The increasing incidence of chronic conditions such as cardiovascular diseases, diabetes, and respiratory illnesses necessitates continuous monitoring of patients' vital signs.

Spot monitors provide healthcare professionals with timely data, enabling better disease management and patient outcomes. Innovations in medical technology, including portable and wireless monitoring devices, have made spot monitors more accessible and user-friendly. These advancements enhance the accuracy and reliability of vital sign measurements, driving their adoption in both clinical and home settings.

Furthermore, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, technological advancements, and product launches & approvals would propel the genital dysfunction drugs market growth. For instance, in April 2024, the FDA clearance of Corsano Health's CardioWatch System marks a significant advancement in remote patient monitoring (RPM) technology, particularly for European systems entering the U.S. market. This patient-friendly, real-time monitoring system is designed to enhance the user experience and address common challenges associated with existing RPM solutions.

Asia Pacific is growing at the fastest pace in the spot monitor market

The rising incidence of chronic conditions in the Asia Pacific region drives the spot monitor market. Spot monitors provide healthcare professionals with timely data that enhances disease management and improves patient outcomes. As technology continues to evolve, these devices will play an increasingly important role in managing chronic diseases effectively, ultimately contributing to better health outcomes for patients across the region.

Furthermore, key player's strategies such as partnerships & collaborations, and product launches would drive this spot market growth in the region. In January 2024, Medtronic announced a strategic partnership with Cardiac Design Labs (CDL) to launch and expand access to a novel heart rhythm monitoring technology called Padma Rhythms in India. This collaboration aims to enhance cardiac care by providing comprehensive, long-term heart monitoring through an External Loop Recorder (ELR) patch.

Also, in October 2023, MicroPort CRM announced the launch of the ULYS Implantable Cardioverter Defibrillator (ICD) and INVICTA defibrillation lead in Japan. This introduction highlights MicroPort's commitment to advancing cardiac care technology and expanding its product offerings in the global spot monitor market.

Competitive Landscape

The major global players in the spot monitor market include Koninklijke Philips N.V., Baxter International Inc., Masimo, Medtronic, GE HealthCare., Mindray DS USA, Inc., Nihon Kohden Corporation, OMRON Healthcare, Inc., ZOLL Medical Corporation, and Contec among others.

Emerging Players

The emerging players in the spot monitor market include HealthSnap, Inc., SmartCardia Inc., iRhythm Technologies, Inc., Turtle Shell Technologies Pvt Ltd, Athelas Incorporated., Accuhealth Technologies LLC, and Bionet among others.

Key Developments

• In October 2023, Boston Scientific launched the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, a next-generation device designed for long-term monitoring of arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke, and syncope. This innovative system enhances the capabilities of cardiac monitoring and aims to improve patient care through advanced technology.

Why Purchase the Report?

• To visualize the global spot monitor market segmentation based on product type, parameters monitored, application, end-user, distribution channel, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the spot monitor market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.

The global spot monitor market report would provide approximately 78 tables, 80 figures, and 183 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies